References
Diagnosis and treatment of dementia
- Iliffe S, Robinson L, Brayne C, Goodman C, Rait G, Manthorpe J et al. Primary care and dementia: 1. diagnosis, screening and disclosure. Int J Geriatr Psychiatry 2009 February 18.
- Martin AJ, Marottoli R, O'Neill D. Driving assessment for maintaining mobility and safety in drivers with dementia. Cochrane Database Syst Rev 2009;(1):CD006222.
- Okonkwo OC, Wadley VG, Griffith HR, Belue K, Lanza S, Zamrini EY et al. Awareness of deficits in financial abilities in patients with mild cognitive impairment: going beyond self-informant discrepancy. Am J Geriatr Psychiatry 2008 August;16(8):650-9.
- Lai JM, Karlawish J. Assessing the capacity to make everyday decisions: a guide for clinicians and an agenda for future research. Am J Geriatr Psychiatry 2007 February;15(2):101-11.
- Brayne C, Fox C, Boustani M. Dementia screening in primary care: is it time? JAMA 2007 November 28;298(20):2409-11.
- Boustani M, Peterson B, Hanson L, Harris R, Lohr KN. Screening for Dementia in Primary Care. Summary of the Evidence. 2003. http://www.ahrq.gov/clinic/3rduspstf/dementia/dementsum.htm
- Boustani M, Peterson B, Hanson L, Harris R, Lohr KN. Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2003 June 3;138(11):927-37.
- Wedderburn C, Wear H, Brown J, Mason SJ, Barker RA, Hodges J et al. The utility of the Cambridge Behavioural Inventory in neurodegenerative disease. J Neurol Neurosurg Psychiatry 2008 May;79(5):500-3.
- Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992 September;40(9):922-35.
- Milne A, Culverwell A, Guss R, Tuppen J, Whelton R. Screening for dementia in primary care: a review of the use, efficacy and quality of measures. Int Psychogeriatr 2008 October;20(5):911-26.
- Cullen B, O'Neill B, Evans JJ, Coen RF, Lawlor BA. A review of screening tests for cognitive impairment. J Neurol Neurosurg Psychiatry 2007 August;78(8):790-9.
- Brodaty H, Low LF, Gibson L, Burns K. What is the best dementia screening instrument for general practitioners to use? Am J Geriatr Psychiatry 2006 May;14(5):391-400.
- Cherbuin N, Anstey KJ, Lipnicki DM. Screening for dementia: a review of self- and informant-assessment instruments. Int Psychogeriatr 2008 June;20(3):431-58.
- Lorentz WJ, Scanlan JM, Borson S. Brief screening tests for dementia. Can J Psychiatry 2002 October;47(8):723-33.
- Holsinger T, Deveau J, Boustani M, Williams JW, Jr. Does this patient have dementia? JAMA 2007 June 6;297(21):2391-404.
- Wild K, Howieson D, Webbe F, Seelye A, Kaye J. Status of computerized cognitive testing in aging: a systematic review. Alzheimers Dement 2008 November;4(6):428-37.
- Brodaty H, Kemp NM, Low LF. Characteristics of the GPCOG, a screening tool for cognitive impairment. Int J Geriatr Psychiatry 2004 September;19(9):870-4.
- Brodaty H, Pond D, Kemp NM, Luscombe G, Harding L, Berman K et al. The GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc 2002 March;50(3):530-4.
- Shulman KI, Herrmann N, Brodaty H, Chiu H, Lawlor B, Ritchie K et al. IPA survey of brief cognitive screening instruments. Int Psychogeriatr 2006 June;18(2):281-94.
- Shulman KI. Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry 2000 June;15(6):548-61.
- Royall DR, Cordes JA, Polk M. CLOX: an executive clock drawing task. J Neurol Neurosurg Psychiatry 1998 May;64(5):588-94.
- Royall DR, Mulroy AR, Chiodo LK, Polk MJ. Clock drawing is sensitive to executive control: a comparison of six methods. J Gerontol B Psychol Sci Soc Sci 1999 September;54(5):328-33.
- Buschke H, Kuslansky G, Katz M, Stewart WF, Sliwinski MJ, Eckholdt HM et al. Screening for dementia with the memory impairment screen. Neurology 1999 January 15;52(2):231-8.
- Jorm AF. The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review. Int Psychogeriatr 2004 September;16(3):275-93.
- Galvin JE, Roe CM, Xiong C, Morris JC. Validity and reliability of the AD8 informant interview in dementia. Neurology 2006 December 12;67(11):1942-8.
- Galvin JE, Roe CM, Powlishta KK, Coats MA, Muich SJ, Grant E et al. The AD8: a brief informant interview to detect dementia. Neurology 2005 August 23;65(4):559-64.
- Galvin JE, Roe CM, Coats MA, Morris JC. Patient's rating of cognitive ability: using the AD8, a brief informant interview, as a self-rating tool to detect dementia. Arch Neurol 2007 May;64(5):725-30.
- Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005 April;53(4):695-9.
- Meulen EF, Schmand B, van Campen JP, de Koning SJ, Ponds RW, Scheltens P et al. The seven minute screen: a neurocognitive screening test highly sensitive to various types of dementia. J Neurol Neurosurg Psychiatry 2004 May;75(5):700-5.
- Kalbe E, Kessler J, Calabrese P, Smith R, Passmore AP, Brand M et al. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry 2004 February;19(2):136-43.
- Williams JG, Huppert FA, Matthews FE, Nickson J. Performance and normative values of a concise neuropsychological test (CAMCOG) in an elderly population sample. Int J Geriatr Psychiatry 2003 July;18(7):631-44.
- Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR. A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology 2000 December 12;55(11):1613-20.
- Randolph C, Tierney MC, Mohr E, Chase TN. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 1998 June;20(3):310-9.
- Hentschel F, Kreis M, Damian M, Krumm B, Frolich L. The clinical utility of structural neuroimaging with MRI for diagnosis and differential diagnosis of dementia: a memory clinic study. Int J Geriatr Psychiatry 2005 July;20(7):645-50.
- Scheltens P, Fox N, Barkhof F, De CC. Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol 2002 May;1(1):13-21.
- Chetelat G, Baron JC. Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging. Neuroimage 2003 February;18(2):525-41.
- van Straaten EC, Scheltens P, Knol DL, van Buchem MA, van Dijk EJ, Hofman PA et al. Operational definitions for the NINDS-AIREN criteria for vascular dementia: an interobserver study. Stroke 2003 August;34(8):1907-12.
- Dougall N, Nobili F, Ebmeier KP. Predicting the accuracy of a diagnosis of Alzheimer's disease with 99mTc HMPAO single photon emission computed tomography. Psychiatry Res 2004 July 30;131(2):157-68.
- O'Brien JT, McKeith IG, Walker Z, Tatsch K, Booij J, Darcourt J et al. Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies. Br J Psychiatry 2009 January;194(1):34-9.
- Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA 2001 November 7;286(17):2120-7.
- Yuan Y, Gu ZX, Wei WS. Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis. AJNR Am J Neuroradiol 2009 February;30(2):404-10.
- Jagust W, Reed B, Mungas D, Ellis W, DeCarli C. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology 2007 August 28;69(9):871-7.
- Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A et al. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging 2008 October;29(10):1456-65.
- Robinson DJ, Merskey H, Blume WT, Fry R, Williamson PC, Hachinski VC. Electroencephalography as an aid in the exclusion of Alzheimer's disease. Arch Neurol 1994 March;51(3):280-4.
- Claus JJ, Strijers RL, Jonkman EJ, Ongerboer d, V, Jonker C, Walstra GJ et al. The diagnostic value of electroencephalography in mild senile Alzheimer's disease. Clin Neurophysiol 1999 May;110(5):825-32.
- Bonanni L, Thomas A, Tiraboschi P, Perfetti B, Varanese S, Onofrj M. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up. Brain 2008 March;131(Pt 3):690-705.
- Zerr I, Schulz-Schaeffer WJ, Giese A, Bodemer M, Schroter A, Henkel K et al. Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants. Ann Neurol 2000 September;48(3):323-9.
- Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E et al. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet 2004 June 26;363(9427):2105-15.
- Wilcock GK, Ballard CG, Cooper JA, Loft H. Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. J Clin Psychiatry 2008 March;69(3):341-8.
- DeKosky ST, Williamson JD, Fitzpatrick AL, Kronmal RA, Ives DG, Saxton JA et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 2008 November 19;300(19):2253-62.
- Birks J, Grimley EJ. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev 2007;(2):CD003120.
- Schneider LS, Ismail MS, Dagerman K, Davis S, Olin J, McManus D et al. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial. Schizophr Bull 2003;29(1):57-72.
- Pollock BG, Mulsant BH, Rosen J, Mazumdar S, Blakesley RE, Houck PR et al. A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. Am J Geriatr Psychiatry 2007 November;15(11):942-52.
Last Updated: Thursday 08 October 2009